RNU2-19P

Across TCGA pan-cancer cohorts, RNU2-19P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU2-19P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU2-19P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU2-19P expression acts as an unfavorable survival marker.

READ, STAD, and SKCM are the cancer types where RNU2-19P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.059	0.845	<.001	108	view →
STAD	OS	Tertile	IV	0.186	0.655	.001	36	view →
SKCM	DFS	Tertile	All	0.225	0.738	.002	36	view →
KIRC	DFS	Tertile	All	0.481	0.638	.044	24	view →
OV	OS	Tertile	IV	0.311	0.765	.021	18	view →
COAD	DFS	Tertile	All	0.188	0.691	.004	18	view →
THCA	DFS	Tertile	IV	0.144	0.884	<.001	18	view →
UCEC	OS	Tertile	All	0.849	0.928	.017	12	view →
ESCA	OS	Tertile	All	0.470	0.906	.017	9	view →
BRCA	OS	Tertile	All	0.909	0.963	.031	6	view →
HNSC	OS	Tertile	All	0.133	0.401	.043	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU2-19P–READ (DFS)

Open the READ breakdown →